Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.08 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.051 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |